MXPA03011802A - Ensayo de diagnostico para parvovirus b19. - Google Patents
Ensayo de diagnostico para parvovirus b19.Info
- Publication number
- MXPA03011802A MXPA03011802A MXPA03011802A MXPA03011802A MXPA03011802A MX PA03011802 A MXPA03011802 A MX PA03011802A MX PA03011802 A MXPA03011802 A MX PA03011802A MX PA03011802 A MXPA03011802 A MX PA03011802A MX PA03011802 A MXPA03011802 A MX PA03011802A
- Authority
- MX
- Mexico
- Prior art keywords
- parvovirus
- diagnostic assays
- primers
- disclosed
- probes
- Prior art date
Links
- 241000702617 Human parvovirus B19 Species 0.000 title abstract 3
- 238000003556 assay Methods 0.000 title abstract 2
- 239000000523 sample Substances 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30207701P | 2001-06-28 | 2001-06-28 | |
| US36595602P | 2002-03-19 | 2002-03-19 | |
| US36922402P | 2002-03-29 | 2002-03-29 | |
| PCT/US2002/020684 WO2003002753A2 (en) | 2001-06-28 | 2002-06-28 | Diagnostic assays for parvovirus b19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03011802A true MXPA03011802A (es) | 2004-04-02 |
Family
ID=28794978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03011802A MXPA03011802A (es) | 2001-06-28 | 2002-06-28 | Ensayo de diagnostico para parvovirus b19. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6936442B2 (enExample) |
| EP (1) | EP1537235B1 (enExample) |
| JP (5) | JP2005511004A (enExample) |
| KR (2) | KR100944674B1 (enExample) |
| CN (1) | CN1324147C (enExample) |
| AU (2) | AU2002318450B2 (enExample) |
| BG (1) | BG66283B1 (enExample) |
| BR (1) | BRPI0211191B8 (enExample) |
| CA (2) | CA2779653C (enExample) |
| CZ (1) | CZ308201B6 (enExample) |
| ES (1) | ES2537549T3 (enExample) |
| HK (1) | HK1080516B (enExample) |
| HU (1) | HU230244B1 (enExample) |
| MX (1) | MXPA03011802A (enExample) |
| NO (1) | NO337901B1 (enExample) |
| NZ (1) | NZ530602A (enExample) |
| PL (1) | PL210849B1 (enExample) |
| RU (1) | RU2301263C2 (enExample) |
| SK (1) | SK15752003A3 (enExample) |
| WO (1) | WO2003002753A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002323520B2 (en) | 2001-08-31 | 2008-02-21 | Gen-Probe Incorporated | Assay for detection of human parvovirus B19 nucleic acid |
| US20120122103A1 (en) | 2003-09-11 | 2012-05-17 | Rangarajan Sampath | Compositions for use in identification of bacteria |
| WO2005071401A2 (en) * | 2004-01-15 | 2005-08-04 | Chiron Corporation | Homogeneous multiplex assay for nucleic acid targets |
| US20060057643A1 (en) * | 2004-09-10 | 2006-03-16 | Mccarthy Laurence R | Methods and compositions for detecting erythrovirus genotypes |
| AU2005333163B2 (en) * | 2004-11-09 | 2011-06-16 | Gen-Probe Incorporated | Compositions and methods for detecting Group A streptococci |
| US8058000B2 (en) | 2005-06-02 | 2011-11-15 | The United States Of America As Represented By The U.S. Environmental Protection Agency | Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment |
| US7572584B2 (en) * | 2005-06-02 | 2009-08-11 | The United States Of America As Represented By The U.S. Environmental Protection Agency | Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment |
| DE102006034844B3 (de) * | 2006-07-27 | 2007-12-06 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Zusammensetzungen und Verfahren zur Amplifikation von Hepatitis A-Viren (HAV) und/oder Parvoviren B19 (PB19) mittels Multiplex-PCR |
| EP2121913A2 (en) | 2007-01-16 | 2009-11-25 | Talecris Biotherapeutics, Inc. | Human erythrovirus |
| US8227583B2 (en) | 2007-06-14 | 2012-07-24 | The Board Of Regents For Oklahoma State University | Vaccines containing canine parvovirus genetic variants |
| WO2009038840A2 (en) * | 2007-06-14 | 2009-03-26 | Ibis Biosciences, Inc. | Compositions for use in identification of adventitious contaminant viruses |
| CN106048082A (zh) * | 2007-06-14 | 2016-10-26 | 俄克拉荷马州大学评议会 | 包含犬细小病毒遗传性变体的疫苗 |
| EP2300819A4 (en) * | 2008-07-23 | 2011-11-23 | Nat Univ Gyeongsang Iacf | METHOD AND SYSTEM FOR VIRUS DIAGNOSIS |
| EP3118208A1 (en) | 2009-02-26 | 2017-01-18 | Gen-Probe Incorporated | Assay for detection of human parvovirus nuleic acid |
| US9598739B1 (en) | 2009-03-13 | 2017-03-21 | Grifols Therapeutics Inc. | Human erythrovirus |
| WO2011127316A1 (en) | 2010-04-07 | 2011-10-13 | Novartis Ag | Method for generating a parvovirus b19 virus-like particle |
| EP3009522B1 (en) | 2011-07-15 | 2019-09-04 | Gen-Probe Incorporated | Method for detecting hepatitis a virus nucleic acids in single-plex or multiplex assays |
| CN103451320B (zh) * | 2013-08-09 | 2015-05-06 | 中国人民解放军军事医学科学院野战输血研究所 | 人细小病毒B19三种基因型的实时荧光定量PCR检测方法及其通用检测引物、TaqMan探针与试剂盒 |
| US9410172B2 (en) * | 2013-09-16 | 2016-08-09 | General Electric Company | Isothermal amplification using oligocation-conjugated primer sequences |
| US10214565B2 (en) | 2014-03-10 | 2019-02-26 | University Of Louisville Research Foundation, Inc. | Compositions and methods for treating, including preventing, parvovirus infections and related diseases |
| CN103820581B (zh) * | 2014-03-17 | 2016-01-13 | 成都蓉生药业有限责任公司 | 一种检测人细小病毒b19的试剂盒和方法 |
| JP6414409B2 (ja) * | 2014-07-29 | 2018-10-31 | 株式会社微生物化学研究所 | 弱毒化パルボウイルスおよび弱毒化パルボウイルスを用いたワクチン |
| WO2016071926A1 (en) * | 2014-11-05 | 2016-05-12 | Indian Council Of Medical Research | In-vitro detection of human parvovirus 4 |
| TWI867535B (zh) * | 2015-03-27 | 2024-12-21 | 美商再生元醫藥公司 | 偵測生物污染物之組成物及方法 |
| CN105158471A (zh) * | 2015-08-24 | 2015-12-16 | 北京中检安泰诊断科技有限公司 | 人细小病毒B19型IgM抗体检测试剂盒及其制备方法 |
| CN114410836B (zh) * | 2021-12-17 | 2024-03-01 | 上海交通大学医学院附属仁济医院 | 一种集样本处理、核酸提取及多重恒温扩增一体化的检测人细小病毒b19的试剂盒和方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5516630A (en) | 1983-09-30 | 1996-05-14 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of detecting hepatitis A virus |
| US5283174A (en) | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
| CA2020958C (en) * | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
| US6204044B1 (en) * | 1989-09-14 | 2001-03-20 | Caroline Sarah Brown | Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| US6287815B1 (en) * | 1989-09-14 | 2001-09-11 | Rijksuniversiteit Te Leiden | Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| NL8902301A (nl) | 1989-09-14 | 1991-04-02 | Rijksuniversiteit | Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins. |
| DE4003826C2 (de) | 1990-02-08 | 1995-11-23 | Mikrogen Molekularbiol Entw | Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19 |
| WO1994010294A1 (en) | 1992-10-23 | 1994-05-11 | New York University | Human monoclonal antibodies to human parvovirus and methods of making and using thereof |
| US5449608A (en) | 1993-03-22 | 1995-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | Parvovirus B19 receptor and parvovirus B19 detection |
| JPH06293798A (ja) | 1993-04-06 | 1994-10-21 | Shin Etsu Chem Co Ltd | ヒトパルボウイルスｂ１９のエピトープ関連ペプチド |
| US5538848A (en) * | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| WO1996009391A2 (en) | 1994-09-22 | 1996-03-28 | Hans Wolf | Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 |
| US6004044A (en) * | 1995-05-03 | 1999-12-21 | Itt Cannon, Inc. | Optoelectric connector |
| JPH0910000A (ja) | 1995-06-26 | 1997-01-14 | Nippon Sekijiyuujishiya | ヒトパルボウイルスの検出方法及びそのための試薬 |
| WO1997018327A1 (fr) * | 1995-11-13 | 1997-05-22 | Shionogi & Co., Ltd. | Diagnostic des maladies associees aux spasmes coronariens |
| WO1997021346A1 (en) | 1995-12-14 | 1997-06-19 | Cerus Corporation | Inactivation of non-enveloped virus |
| US6094338A (en) * | 1997-07-09 | 2000-07-25 | Mitsubishi Chemical Corporation | Electric double-layer capacitor |
| WO1999018227A1 (en) | 1997-10-08 | 1999-04-15 | Advanced Research And Technology Institute | Chimeric parvovirus-based recombinant vector system that specifically targets the erythroid lineage |
| DE19752898A1 (de) | 1997-11-28 | 1999-08-05 | Centeon Pharma Gmbh | Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion |
| JP4388694B2 (ja) * | 1998-02-04 | 2009-12-24 | アプライド バイオシステムズ， エルエルシー | 複数のアレル部位における増幅産物のゲノム型決定 |
| RU2146372C1 (ru) * | 1998-04-16 | 2000-03-10 | Гематологический научный центр РАМН | Способ определения парвовируса б19 |
| US6238860B1 (en) * | 1998-11-05 | 2001-05-29 | Dyax Corp. | Binding moieties for human parvovirus B19 |
| US6642033B1 (en) * | 1999-07-20 | 2003-11-04 | V.I. Technologies, Inc. | Nucleic acids for detecting parvovirus and methods of using same |
| US6294338B1 (en) * | 1999-07-23 | 2001-09-25 | Gen-Probe Incorporated | Polynucleotide amplification method |
-
2002
- 2002-06-28 WO PCT/US2002/020684 patent/WO2003002753A2/en not_active Ceased
- 2002-06-28 EP EP02748013.6A patent/EP1537235B1/en not_active Expired - Lifetime
- 2002-06-28 NZ NZ530602A patent/NZ530602A/en not_active IP Right Cessation
- 2002-06-28 CA CA2779653A patent/CA2779653C/en not_active Expired - Lifetime
- 2002-06-28 PL PL368049A patent/PL210849B1/pl unknown
- 2002-06-28 MX MXPA03011802A patent/MXPA03011802A/es active IP Right Grant
- 2002-06-28 CZ CZ2003-3516A patent/CZ308201B6/cs not_active IP Right Cessation
- 2002-06-28 SK SK1575-2003A patent/SK15752003A3/sk unknown
- 2002-06-28 BR BRPI0211191A patent/BRPI0211191B8/pt not_active IP Right Cessation
- 2002-06-28 RU RU2004102205/13A patent/RU2301263C2/ru active
- 2002-06-28 ES ES02748013.6T patent/ES2537549T3/es not_active Expired - Lifetime
- 2002-06-28 HU HU0600779A patent/HU230244B1/hu not_active IP Right Cessation
- 2002-06-28 US US10/187,253 patent/US6936442B2/en not_active Expired - Lifetime
- 2002-06-28 HK HK06100271.4A patent/HK1080516B/zh not_active IP Right Cessation
- 2002-06-28 JP JP2003508717A patent/JP2005511004A/ja active Pending
- 2002-06-28 KR KR1020087029745A patent/KR100944674B1/ko not_active Expired - Fee Related
- 2002-06-28 KR KR1020037017171A patent/KR100888377B1/ko not_active Expired - Fee Related
- 2002-06-28 CN CNB028128168A patent/CN1324147C/zh not_active Expired - Fee Related
- 2002-06-28 AU AU2002318450A patent/AU2002318450B2/en not_active Ceased
- 2002-06-28 CA CA002451756A patent/CA2451756A1/en not_active Abandoned
-
2003
- 2003-12-19 NO NO20035732A patent/NO337901B1/no not_active IP Right Cessation
-
2004
- 2004-01-13 BG BG108526A patent/BG66283B1/bg unknown
-
2005
- 2005-05-23 US US11/135,189 patent/US20050221300A1/en not_active Abandoned
-
2007
- 2007-11-05 AU AU2007231822A patent/AU2007231822B2/en not_active Ceased
-
2008
- 2008-08-21 JP JP2008213329A patent/JP2009011324A/ja not_active Withdrawn
-
2011
- 2011-11-11 JP JP2011247977A patent/JP2012075440A/ja not_active Withdrawn
-
2013
- 2013-12-27 JP JP2013271027A patent/JP6026401B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-28 JP JP2016148172A patent/JP2016182149A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03011802A (es) | Ensayo de diagnostico para parvovirus b19. | |
| SG149063A1 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
| FR2863861B1 (fr) | Instrument chirurgical de type declipseuse pour implant rachidien. | |
| WO2001047944A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| WO2002018641A3 (en) | Detection of cyp3a4 and cyp2c9 polymorphisms | |
| IL157280A0 (en) | Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv | |
| WO2004041158A3 (en) | Rifalazil compositions and therapeutic regimens | |
| WO2000029623A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| WO2004076614A3 (de) | Humane nukleinsäuresequenzen aus prostatakarzinomen | |
| NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
| WO2001040521A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| PT1328289E (pt) | Proteínas oxidadas e sua actividade biológica e terapêutica, assim como sua utilização em diagnóstico através da inibição da interacção entre as proteínas oxidadas e cd36 | |
| DE69914200D1 (de) | Aminoiminochinon und aminochinon alkaloid verbindungen als caspase inhibitoren | |
| WO2001051670A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| ATE473295T1 (de) | Nukleotidträger zur diagnose und therapie oraler erkrankungen | |
| EP1573055A4 (en) | GENETIC DEPRESSION DIAGNOSIS | |
| NO20042542L (no) | Anvendelse av ascomycin for behandling av blefarit | |
| AU2003296820A8 (en) | Epitopic peptides of the thyroperoxidase enzyme, compositions containing same and uses thereof | |
| AU2002366101A8 (en) | Hybrid oligonucleotide primers for amplification of dna and uses thereof | |
| WO2000029622A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| HUP0302801A3 (en) | Dna sequence of the enzyme phospholipase a1 ciliate tetrahymena, and the use of same | |
| WO2003046143A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| ATE238347T1 (de) | Gen des familiären mittelmeerfiebers | |
| WO2003018052A8 (en) | Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments | |
| IT1317403B1 (it) | Vassoio per il contenimento di strumenti chirurgici. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status | ||
| FG | Grant or registration |